‌

US Patent 12071438 Crystal forms of an ALK2 inhibitor

Patent 12071438 was granted and assigned to Keros Therapeutics on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Keros Therapeutics

0

Current Assignee

Keros Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Sarah Bethune0

Krista Diaz0

Catherine A. Evans0

Date of Patent

August 27, 2024

0

Patent Application Number

172389860

Date Filed

April 23, 2021

0

Patent Citations

US Patent 10513521 Compositions and methods for inhibiting BMP

0

US Patent 10669277 Inhibitors of activin receptor-like kinase

0

US Patent 11654147 ALK2 inhibitors and methods for inhibiting BMP signaling

0

US Patent 11026947 ALK2 inhibitors and methods for inhibiting BMP signaling

0

US Patent 8507501 Inhibitors of the BMP signaling pathway

0

US Patent 9045484 Inhibitors of the BMP signaling pathway

0

US Patent 9682983 BMP inhibitors and methods of use thereof

0

US Patent 10017516 BMP inhibitors and methods of use thereof

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

The invention relates to crystalline forms of an ALK2 inhibitor, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to pharmaceutical uses of the crystalline forms.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12071438 Crystal forms of an ALK2 inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.